跳至主要内容
临床试验/JPRN-UMIN000028259
JPRN-UMIN000028259招募中2 期

The efficacy of additional metformin to aspirin for human rectal aberrant crypt foci: double-blinded randomized controlled trial - The efficacy of aspirin and metformin for rectal ACF

Yokohama City University0 个研究点目标入组 60 人开始时间: 2017年7月18日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with lesion which preferred early resection. 2.History of regular use (defined as at least once per week) of NSAIDs and/or aspirin. 3.History of regular use of warfarin and/or DOAC. 4.History of diabetes mellitus (defined as more than HbA1c 6.5% or regular use of anti-diabetic drugs) . 5.History of heart failure, renal failure, liver cirrhosis or chronic hepatic failure 6.History of familial adenomatous polyposis, hereditary non-polyposis colorectal cancer and inflammatory bowel disease 7.Pregnancy or possibility of pregnancy 8.Contraindication to aspirin or metformin 9.Allergy to aspirin or metformin 10.Patients judged as inappropriate candidates for the trial by the investigators

研究者

相似试验